The best of R&I and around the web, handpicked by our editors.
White papers, service directory and conferences for the R&I community.
Web replica of the print magazine.
The use of a host of strategies and tools, spurred on by the pandemic, is poised to face down mental health challenges in injured workers.
High prices and uncertain efficacy make workers’ comp professionals question compound drugs.
Pharmaceuticals can do as much harm as good. Payers can help keep treatments in check.
An injured deli counter clerk abuses her prescription medications.
Experts warn that by 2018 specialty drug costs could rise to 50 percent of total drug costs for workers’ comp payers.
The growing trend of compound drug prescribing raises safety concerns and obscures costs.
More customers benefit from digital risk services from carriers and vendors.
Study connects poor outcomes to early opioid treatment.
New CDC findings on opioid abuse point to need for prescription curbs.
Federal drug laws are woefully outdated.
A flat fee for bill review services would bring transparency to TPA service charges.
Rate cuts for pain management procedures may have repercussions for workers’ comp.
Legislation to regulate group health pharmacy benefit managers could impact workers’ comp payers.
Eight thought leaders in the workers’ comp industry share their top issues of concerns for the coming years.
Florida’s E-Force program is proving effective in reducing prescription-related deaths and overall prescribing volume.
A new report offers guidance for continued efforts to place tight controls on opioid prescribing.
A routine back injury evolves into chronic pain.
The worst of times is over. Maybe that’s not saying very much.
States are increasing regulation to limit physician distributed prescriptions.
A once fit, hardworking man in his sixties gets hurt and his case goes into an unexpected tailspin. Will Ben ever return to work?
An already fragile bank teller is knocked down and cannot get back up, thanks to her appetite for prescription painkillers.